ENGN enGene Therapeutics Inc.
Nasdaq · SEC CIK 1980845 · EDGAR
- Bought, last 12 months
- $10.1K 1 purchases by 1 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 65 since 2023-11-02, latest 2026-09-24 16:40
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Grossman William | Interim Chief Medical Off, Dir | $10.1K | — |
Transactions 13
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-24 16:40 | 2026-09-22 | ENGN | Grossman William | Interim Chief Medical Off, Dir | P - Purchase | $1.97 | +5,102 | 5,102 | New | +$10.1K | |
| 2024-11-01 | 2024-10-30 | ENGN | Forbion Growth Management B.V. | 10% | P - Purchase | $8.90 | +561.8K | 3.03M | +23% | +$5.00M | |
| M | 2024-10-18 | 2023-12-27+ | ENGN | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% | P - Purchase | $6.40 | +470.6K | 2.46M | +24% | +$3.01M |
| 2024-10-01 | 2024-09-27 | ENGN | Cooper Ronald Harold Wilfred | CEO, Dir | P - Purchase | $5.70 | +10.0K | 10.0K | New | +$57.0K | |
| D | 2024-05-29 | 2024-05-28 | ENGN | Glickman Richard M | Dir | M - OptEx | $0.89 | +120 | 24.7K | +0.5% | +$106.80 |
| M | 2024-04-22 | 2024-04-18+ | ENGN | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 10% | S - Sale | $15.00 | -52.5K | 3.08M | -2% | -$788.0K |
| D | 2024-03-20 | 2024-03-18 | ENGN | CHEUNG ANTHONY TZEYEW | CTO | M - OptEx | $0.89 | +52.9K | 102.9K | +106% | +$47.1K |
| MI | 2024-02-21 | 2024-02-20 | ENGN | BRUNK GERALD A | Dir, 10% | A - Grant | $10.00 | +800.0K | 238.9K | New | +$8.00M |
| MI | 2024-02-21 | 2024-02-20 | ENGN | Lumira Capital Investment Management Inc. | 10% | A - Grant | $10.00 | +800.0K | 993.7K | +413% | +$8.00M |
| D | 2023-11-02 | 2023-10-31 | ENGN | Glickman Richard M | Dir | A - Grant | — | +24.6K | 24.6K | New | — |
| DMI | 2023-11-02 | 2023-10-31 | ENGN | Forbion Growth Sponsor FEAC I B.V. | 10% | J - Other | — | +2.39M | 1.50M | New | — |
| DMI | 2023-11-02 | 2023-10-31 | ENGN | BRUNK GERALD A | Dir, 10% | A - Grant | — | +3.05M | 44.6K | New | — |
| D | 2023-11-02 | 2023-10-31 | ENGN | CHEUNG ANTHONY TZEYEW | CTO | A - Grant | — | +49.9K | 49.9K | New | — |
Purchase Sale Sale after option exercise All abbreviations